Methods For Administering Hypoglycemic Agents

Patent No. EP1965823 (titled "Methods For Administering Hypoglycemic Agents") was filed by Glaxosmithkline on Nov 3, 2006. The application was issued on May 18, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELI LILLYFeb 20, 2017INGHAM
GENERICS UKFeb 17, 2017ELKINGTON AND FIFE
SANOFIFeb 16, 2017ZWICKER
NOVO NORDISKFeb 16, 2017POTTER CLARKSON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1965823

GLAXOSMITHKLINE
Application Number
EP06839697A
Filing Date
Nov 3, 2006
Status
Revoked
Nov 22, 2024
Publication Date
May 18, 2016